China COVID Clinical Trials Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the COVID Clinical Trials industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Medidata Solutions

    • IQVIA

    • PPD, Inc

    • Moderna

    • Bioclinica

    • Gilead Sciences Inc

    • ICON Plc

    • BioNTech SE

    • Novartis

    • GlaxoSmithKline

    • Novavax

    • Parexel

    • Johnson & Johnson

    • Pfizer

    • Covance

    By Type:

    • Phase II

    • Phase I

    • Others

    • Phase III

    • Phase IV

    By Application:

    • Vaccines

    • Therapeutics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China COVID Clinical Trials Market Overview 2018-2029

    • 1.1 China COVID Clinical Trials Industry Development Overview

    • 1.2 China COVID Clinical Trials Industry Development History

    • 1.3 China COVID Clinical Trials Industry Market Size (2018-2029)

    • 1.4 China COVID Clinical Trials Market Analysis by Type from Production Side

      • 1.4.1 China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Phase II (2018-2029)

      • 1.4.2 China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Phase I (2018-2029)

      • 1.4.3 China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Phase III (2018-2029)

      • 1.4.5 China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Phase IV (2018-2029)

    • 1.5 China COVID Clinical Trials Market Analysis by Application from Consumption End

      • 1.5.1 China COVID Clinical Trials Sales Volume, Sales Value and Growth Rate of Vaccines (2018-2029)

      • 1.5.2 China COVID Clinical Trials Sales Volume, Sales Value and Growth Rate of Therapeutics (2018-2029)

    • 1.6 China COVID Clinical Trials Market Analysis by Region

      • 1.6.1 North China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

    Chapter 2 China COVID Clinical Trials Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on COVID Clinical Trials Market Status and Competition at home and abroad in 2023

      • 2.2.2 China COVID Clinical Trials Market Status and Competition Analysis in 2023

      • 2.2.3 China COVID Clinical Trials Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China COVID Clinical Trials Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on COVID Clinical Trials Industry Development

    Chapter 3 COVID Clinical TrialsIndustry Chain Analysis

    • 3.1 COVID Clinical Trials Industry Chain

    • 3.2 COVID Clinical Trials Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the COVID Clinical Trials Market

    • 3.3 COVID Clinical Trials Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the COVID Clinical Trials Market

    Chapter 4 China COVID Clinical Trials Market, by Type

    • 4.1 China COVID Clinical Trials Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China COVID Clinical Trials Total Production Volume and Growth Rate from Production Side

    • 4.5 China COVID Clinical Trials Production Volume and Growth Rate, by Type

      • 4.5.1 China COVID Clinical Trials Production Volume and Growth Rate of Phase II

      • 4.5.2 China COVID Clinical Trials Production Volume and Growth Rate of Phase I

      • 4.5.3 China COVID Clinical Trials Production Volume and Growth Rate of Others

      • 4.5.4 China COVID Clinical Trials Production Volume and Growth Rate of Phase III

      • 4.5.5 China COVID Clinical Trials Production Volume and Growth Rate of Phase IV

    Chapter 5 China COVID Clinical Trials Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China COVID Clinical Trials Total Market Size and Growth Rate from Consumption End

    • 5.5 China COVID Clinical Trials Market Size and Growth Rate, by Application

      • 5.5.1 China COVID Clinical Trials Market Size and Growth Rate of Vaccines

      • 5.5.2 China COVID Clinical Trials Market Size and Growth Rate of Therapeutics

    Chapter 6 China COVID Clinical Trials Market, by Region

    • 6.1 China COVID Clinical Trials Production Volume and Production Value, by Region

    • 6.2 China COVID Clinical Trials Sales Volume and Sales Value, by Region

    Chapter 7 North China COVID Clinical Trials Market Analysis

    • 7.1 North China COVID Clinical Trials Market, by Type

    • 7.2 North China COVID Clinical Trials Market, by Application

    Chapter 8 Central China COVID Clinical Trials Market Analysis

    • 8.1 Central China COVID Clinical Trials Market, by Type

    • 8.2 Central China COVID Clinical Trials Market, by Application

    Chapter 9 South China COVID Clinical Trials Market Analysis

    • 9.1 South China COVID Clinical Trials Market, by Type

    • 9.2 South China COVID Clinical Trials Market, by Application

    Chapter 10 East China COVID Clinical Trials Market Analysis

    • 10.1 East China COVID Clinical Trials Market, by Type

    • 10.2 East China COVID Clinical Trials Market, by Application

    Chapter 11 Northeast China COVID Clinical Trials Market Analysis

    • 11.1 Northeast China COVID Clinical Trials Market, by Type

    • 11.2 Northeast China COVID Clinical Trials Market, by Application

    Chapter 12 Southwest China COVID Clinical Trials Market Analysis

    • 12.1 Southwest China COVID Clinical Trials Market, by Type

    • 12.2 Southwest China COVID Clinical Trials Market, by Application

    Chapter 13 Northwest China COVID Clinical Trials Market Analysis

    • 13.1 Northwest China COVID Clinical Trials Market, by Type

    • 13.2 Northwest China COVID Clinical Trials Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Medidata Solutions

        • 14.1.1 Medidata Solutions Company Profile

        • 14.1.2 Medidata Solutions COVID Clinical Trials Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 IQVIA

        • 14.2.1 IQVIA Company Profile

        • 14.2.2 IQVIA COVID Clinical Trials Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 PPD, Inc

        • 14.3.1 PPD, Inc Company Profile

        • 14.3.2 PPD, Inc COVID Clinical Trials Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Moderna

        • 14.4.1 Moderna Company Profile

        • 14.4.2 Moderna COVID Clinical Trials Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bioclinica

        • 14.5.1 Bioclinica Company Profile

        • 14.5.2 Bioclinica COVID Clinical Trials Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Gilead Sciences Inc

        • 14.6.1 Gilead Sciences Inc Company Profile

        • 14.6.2 Gilead Sciences Inc COVID Clinical Trials Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 ICON Plc

        • 14.7.1 ICON Plc Company Profile

        • 14.7.2 ICON Plc COVID Clinical Trials Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 BioNTech SE

        • 14.8.1 BioNTech SE Company Profile

        • 14.8.2 BioNTech SE COVID Clinical Trials Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Novartis

        • 14.9.1 Novartis Company Profile

        • 14.9.2 Novartis COVID Clinical Trials Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 GlaxoSmithKline

        • 14.10.1 GlaxoSmithKline Company Profile

        • 14.10.2 GlaxoSmithKline COVID Clinical Trials Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Novavax

        • 14.11.1 Novavax Company Profile

        • 14.11.2 Novavax COVID Clinical Trials Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Parexel

        • 14.12.1 Parexel Company Profile

        • 14.12.2 Parexel COVID Clinical Trials Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Johnson & Johnson

        • 14.13.1 Johnson & Johnson Company Profile

        • 14.13.2 Johnson & Johnson COVID Clinical Trials Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Pfizer

        • 14.14.1 Pfizer Company Profile

        • 14.14.2 Pfizer COVID Clinical Trials Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Covance

        • 14.15.1 Covance Company Profile

        • 14.15.2 Covance COVID Clinical Trials Market Performance

        • 14.15.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 COVID Clinical Trials Industry Research Conclusions

    • 15.2 COVID Clinical Trials Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China COVID Clinical Trials Industry Market Size (2018-2029)

    • Figure China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Phase II (2018-2029)

    • Figure China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Phase I (2018-2029)

    • Figure China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Phase III (2018-2029)

    • Figure China COVID Clinical Trials Production Volume, Production Value and Growth Rate of Phase IV (2018-2029)

    • Figure China COVID Clinical Trials Sales Volume, Sales Value and Growth Rate of Vaccines (2018-2029)

    • Figure China COVID Clinical Trials Sales Volume, Sales Value and Growth Rate of Therapeutics (2018-2029)

    • Figure North China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

    • Figure Central China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

    • Figure South China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

    • Figure East China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

    • Figure Northeast China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

    • Figure Southwest China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

    • Figure Northwest China COVID Clinical Trials Market Size and Growth Rate from 2018-2029

    • Figure COVID Clinical Trials Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China COVID Clinical Trials Market Share by Type in 2018

    • Figure China COVID Clinical Trials Market Share by Type in 2023

    • Figure China COVID Clinical Trials Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China COVID Clinical Trials Production Volume and Growth Rate of Phase II (2018-2023)

    • Figure China COVID Clinical Trials Production Volume and Growth Rate of Phase I (2018-2023)

    • Figure China COVID Clinical Trials Production Volume and Growth Rate of Others (2018-2023)

    • Figure China COVID Clinical Trials Production Volume and Growth Rate of Phase III (2018-2023)

    • Figure China COVID Clinical Trials Production Volume and Growth Rate of Phase IV (2018-2023)

    • Figure China COVID Clinical Trials Market Share by Application in 2018

    • Figure China COVID Clinical Trials Market Share by Application in 2023

    • Figure China COVID Clinical Trials Total Market Size and Growth Rate from Consumption End

    • Figure China COVID Clinical Trials Market Size and Growth Rate of Vaccines (2018-2023)

    • Figure China COVID Clinical Trials Market Size and Growth Rate of Therapeutics (2018-2023)

    • Table China COVID Clinical Trials Production Volume by Region (2018-2023)

    • Table China COVID Clinical Trials Production Volume Share by Region (2018-2023)

    • Figure China COVID Clinical Trials Production Volume Share by Region (2018-2023)

    • Table China COVID Clinical Trials Production Value by Region (2018-2023)

    • Table China COVID Clinical Trials Production Value Share by Region (2018-2023)

    • Figure China COVID Clinical Trials Production Value Share by Region (2018-2023)

    • Table China COVID Clinical Trials Sales Volume by Region (2018-2023)

    • Table China COVID Clinical Trials Sales Volume Share by Region (2018-2023)

    • Figure China COVID Clinical Trials Sales Volume Share by Region (2018-2023)

    • Table China COVID Clinical Trials Sales Value by Region (2018-2023)

    • Table China COVID Clinical Trials Sales Value Share by Region (2018-2023)

    • Figure China COVID Clinical Trials Sales Value Share by Region (2018-2023)

    • Table North China COVID Clinical Trials Production Volume by Type (2018-2023)

    • Table North China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Figure North China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Table North China COVID Clinical Trials Sales Volume by Application (2018-2023)

    • Table North China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Figure North China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Table Central China COVID Clinical Trials Production Volume by Type (2018-2023)

    • Table Central China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Figure Central China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Table Central China COVID Clinical Trials Sales Volume by Application (2018-2023)

    • Table Central China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Figure Central China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Table South China COVID Clinical Trials Production Volume by Type (2018-2023)

    • Table South China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Figure South China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Table South China COVID Clinical Trials Sales Volume by Application (2018-2023)

    • Table South China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Figure South China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Table East China COVID Clinical Trials Production Volume by Type (2018-2023)

    • Table East China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Figure East China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Table East China COVID Clinical Trials Sales Volume by Application (2018-2023)

    • Table East China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Figure East China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Table Northeast China COVID Clinical Trials Production Volume by Type (2018-2023)

    • Table Northeast China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Figure Northeast China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Table Northeast China COVID Clinical Trials Sales Volume by Application (2018-2023)

    • Table Northeast China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Figure Northeast China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Table Southwest China COVID Clinical Trials Production Volume by Type (2018-2023)

    • Table Southwest China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Figure Southwest China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Table Southwest China COVID Clinical Trials Sales Volume by Application (2018-2023)

    • Table Southwest China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Figure Southwest China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Table Northwest China COVID Clinical Trials Production Volume by Type (2018-2023)

    • Table Northwest China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Figure Northwest China COVID Clinical Trials Production Volume Share by Type (2018-2023)

    • Table Northwest China COVID Clinical Trials Sales Volume by Application (2018-2023)

    • Table Northwest China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Figure Northwest China COVID Clinical Trials Sales Volume Share by Application (2018-2023)

    • Table Medidata Solutions Company Profile

    • Table Medidata Solutions COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table IQVIA Company Profile

    • Table IQVIA COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table PPD, Inc Company Profile

    • Table PPD, Inc COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table Moderna Company Profile

    • Table Moderna COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table Bioclinica Company Profile

    • Table Bioclinica COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences Inc Company Profile

    • Table Gilead Sciences Inc COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table ICON Plc Company Profile

    • Table ICON Plc COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table BioNTech SE Company Profile

    • Table BioNTech SE COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table Novavax Company Profile

    • Table Novavax COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table Parexel Company Profile

    • Table Parexel COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer COVID Clinical Trials Revenue, Price and Gross (2018-2023)

    • Table Covance Company Profile

    • Table Covance COVID Clinical Trials Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.